Item 9A. Controls and Procedures
ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer recognize that these controls, no matter how well designed and operated, cannot provide absolute assurance that the objectives of these controls will be met.
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2026. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2026.
Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) and for the assessment of the effectiveness of our internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with U.S. GAAP. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of assets, (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, (iii) provide reasonable assurance that receipts and expenditures are being made only in accordance with authorizations of management and directors, and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has assessed the effectiveness of our internal control over financial reporting as of June 30, 2026. In making this assessment, our management used the criteria established in “ Internal Control — Integrated Framework ” issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). As a result of this assessment and those criteria, our management has determined that our internal control over financial reporting was effective as of June 30, 2026.
The effectiveness of the Company’s internal control over financial reporting as of June 30, 2026 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report, which appears in Part II, Item 8, of this Annual Report on Form 10-K.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(d), under the Exchange Act that occurred during the period covered by this Form 10-K that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
100
Table of Contents
ITEM 9B. OTHER INFORMATION
(b) Trading Plans
During the three months ended June 30, 2026, the Company’s directors or Section 16 officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated (including by modification) a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408 of Regulation S-K as follows:
On June 8, 2026, Mr. David Afdahl , the Company's Chief Operating Officer , adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 28,319 shares of the Company's common stock between September 7, 2026 and June 8, 2027 , subject to such shares reaching certain price points.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this item is incorporated by reference to the Company’s Proxy Statement for its 2026 Annual Meeting of Shareholders to be filed with the SEC within 120 days after the end of the fiscal year ended June 30, 2026.
See also Information about our Executive Officers in Part I of this Form 10-K.
Our Board has adopted a code of business conduct and ethics (the “Code”) that is applicable to all directors, officers and employees, including our principal executive, financial and accounting officers and all persons performing similar functions. A copy of this Code is available on our website at www.ibex.co. We intend to disclose future amendments to certain provisions of the Code, and waivers of the Code granted to executive officers and directors, on the website within four business days following the date of the amendment or waiver.
We have also adopted a securities trading policy governing the purchase, sale and other dispositions of our securities that applies to our directors, officers, employees and other covered persons. We believe that our securities trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, and Nasdaq listing standards applicable to us. Our securities trading policy is included as Exhibit 19.1 to this Form 10-K.
ITEM 11. EXECUTIVE COMPENSATION
The information required by this item is incorporated by reference to the Company’s Proxy Statement for its Annual 2026 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of fiscal year ended June 30, 2026.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by this item is incorporated by reference to the Company’s Proxy Statement for its Annual 2026 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of fiscal year ended June 30, 2026.
101
Table of Contents
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this item is incorporated by reference to the Company’s Proxy Statement for its Annual 2026 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of fiscal year ended June 30, 2026.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this item is incorporated by reference to the Company’s Proxy Statement for its Annual 2026 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of fiscal year ended June 30, 2026.
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following are filed as a part of this Form 10-K:
1) Index to Consolidated Financial Statements and Schedule
Report of Independent Registered Public Accounting Firm (Deloitte & Touche LLP, Tampa, Florida;
PCAOB ID Number 34)
Consolidated Balance Sheets
Consolidated Statements of Comprehensive Income
Consolidated Statements of Stockholders’ Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
Our Consolidated Financial Statements are listed in the “Index to Consolidated Financial Statements” under Part II, Item 8 of this Form 10-K.
2) Financial Statement Schedules
All schedules have been omitted because they are not required, not applicable, or the required information is otherwise included.
3) Exhibits
See exhibits listed under Part (b) below.
(b) Exhibits:
EXHIBIT INDEX
Incorporated by Reference
Exhibit
Number Description of Document Form File Number Exhibit Filing
Date Filed or
Furnished
Herewith
3.1 Memorandum of Association
F-1 333-239821 3.1 07/29/2020
3.2 Amended and Restated Bye-laws
20-F 001-38442 1.2 10/23/2020
4.1 Description of share capital registered under Section 12 of the Exchange Act
10-K 001-38442 4.1 09/13/2023
10.1 Registration Rights Agreement, dated as of September 15, 2017, by and between IBEX Limited and The Resource Company International Limited
F-1 333-239821 10.1 07/10/2020
102
Table of Contents
Incorporated by Reference
Exhibit
Number Description of Document Form File Number Exhibit Filing
Date Filed or
Furnished
Herewith
10.2 Stockholders’ Agreement, dated as of September 15, 2017, by and between IBEX Limited and The Resource Company International Limited
F-1 333-239821 10.2 07/10/2020
10.3# Second Amended and Restated Warrant, dated November 13, 2017, issued to Amazon.com NV Investment Holdings LLC (amended December 28, 2018)
F-1 333-239821 10.40 07/29/2020
10.4 First Amendment to Second Amended and Restated Warrant, dated November 13, 2017, issued to Amazon.com NV Investment Holdings LLC (amended December 27, 2019)
F-1 333-239821 10.41 07/10/2020
10.5* Second Amendment to Second Amended and Restated Warrant, dated November 13, 2017, issued to Amazon.com NV Investment Holdings LLC (amended as of August 7, 2020)
10-K 001-38442 10.26 09/12/2024
10.6^ IBEX Holdings Limited 2018 Restricted Share Plan
F-1 333-239821 10.35 07/10/2020
10.6.1^ Form of Restricted Share Agreement (A)
F-1 333-239821 10.36 07/10/2020
10.6.2^ Form of Restricted Share Agreement (B)
F-1 333-239821 10.37 07/10/2020
10.6.3^ IBEX Holdings Limited UK Sub-Plan of the 2018 Restricted Share Plan
F-1 333-239821 10.38 07/10/2020
10.7^ IBEX Limited Amended and Restated 2020 Long-Term Incentive Plan, dated December 5, 2025
10-Q 001-38442 10.5 02/05/2026
10.8^ Ibex Management Incentive Plan
X
10.9^ Ibex Global Solutions (Philippines) Inc. Amended & Restated Phantom Stock Plan, effective June 30, 2025
10-Q 001-38442 10.4 02/05/2026
10.9A^ Ibex Global Solutions (Philippines) Inc. Phantom Stock Plan Form of Award Agreement, effective June 30, 2025
X
10.10^ Ibex Global Jamaica Limited Amended & Restated Phantom Stock Plan, effective June 30, 2025
10-Q 001-38442 10.3 02/05/2026
10.10A^ Ibex Global Jamaica Limited Phantom Stock Plan Form of Award Agreement, effective June 30, 2025
X
10.11^ Form of Director Agreement
F-1 333-239821 10.42 07/10/2020
10.12^ Form of Director Indemnification Agreement
F-1 333-239821 10.44 07/10/2020
10.13 Executive Employment Agreement dated April 2, 2015 by and between TRG Customer Solutions Inc. and Robert Dechant
10-K 001-38442 10.33 09/13/2023
103
Table of Contents
Incorporated by Reference
Exhibit
Number Description of Document Form File Number Exhibit Filing
Date Filed or
Furnished
Herewith
10.14 Restated Executive Employment Agreement dated July 1, 2020 by and between Ibex Global Solutions Inc. and David Afdahl
10-K 001-38442 10.34 09/13/2023
10.15 Restated Executive Employment Agreement dated July 1, 2020 by and between Ibex Global Solutions Inc. and Julie Casteel
10-K 001-38442 10.35 09/13/2023
10.16 Executive Separation and Release Agreement dated June 4, 2024 by and between Ibex Global Solutions, Inc. and Jeffrey Cox
10-K 001-38442 10.38 09/12/2024
10.17 Restated Executive Employment Agreement dated July 1, 2020 by and between Ibex Global Solutions, Inc. and Bruce Dawson
10-K 001-38442 10.40 09/12/2024
10.18 Executive Employment Agreement dated August 1, 2023 by and between Ibex Global Solutions, Inc. and Taylor Greenwald
10-Q 001-38442 10.10 11/09/2023
10.19 Executive Employment Agreement dated September 1, 2024 by and between Ibex Global Solutions, Inc. and Andreas Wilkens
10-Q 001-38442 10.10 11/07/2024
10.20 Executive Separation and Release Agreement dated November 6, 2025 by and between Ibex Global Solutions, Inc. and Andreas Wilkens
10-Q 001-38442 10.2 02/05/2026
10.21 Executive Employment Agreement dated October 1, 2025 by and between Ibex Global Solutions, Inc. and Michael Ringman
10-Q 001-38442 10.1 02/05/2026
10.22 Restated Employment Agreement dated January 1, 2021 by and between Ibex Global Solutions, Inc. and Michael Darwal
10-Q 001-38442 10.1 05/06/2026
10.23 Amendment to Restated Employment Agreement dated January 1, 2026 by and between Ibex Global Solutions, Inc. and Michael Darwal
10-Q 001-38442 10.2 05/06/2026
10.24^ Form of Officer Indemnity Agreement
10-K 001-38442 10.41 09/12/2024
10.25^ Form of First Amendment to Officer Indemnity Agreement
10-K 001-38442 10.42 09/12/2024
10.26# Credit Agreement, dated as of October 29, 2 0 24, by and among Ibex Global Solutions, Inc., Ibex Limited, Ibex Global Limited, the other borrowers party thereto from time to time, the guarantors party thereto from time to time, the lenders party thereto from time to time and HSBC Bank USA, National Associations, as Administrative Agent
8-K 001-38442 10.1 11/04/2024
10.27A Revolving Loan Agreement, dated as of October 22, 2024, by and between HSBC Bank Middle East Limited and Ibex Global FZ-LLC
8-K 001-38442 10.2A 11/04/2024
104
Table of Contents
Incorporated by Reference
Exhibit
Number Description of Document Form File Number Exhibit Filing
Date Filed or
Furnished
Herewith
10.27B Facility Offer Letter, dated as of October 22, 2024, by and between HSBC Bank Middle East Limited and Ibex Global FZ-LLC
8-K 001-38442 10.2B 11/04/2024
10.27C General Terms and Conditions of the HSBC Bank Middle East Limited
8-K 001-38442 10.2C 11/04/2024
10.27D Letter of Deviation, dated as of October 22, 2024, by and between HSBC Bank Middle East Limited and Ibex Global FZ-LLC
8-K 001-38442 10.2D 11/04/2024
10.28 First Amendment to the Facility Offer Letter, dated May 22, 2025, by and between HSBC Bank Middle East Limited and Ibex Global FZ-LLC
10-K 001-38442 10.24 09/11/2025
10.29 Second Amendment to the Facility Offer Letter, dated May 6 , 2026 by and between HSBC Bank Middle East Limited and Ibex Global FZ-LLC
X
10.30 Call Option Agreement, dated November 19, 2024, by and between the Company and TRGI
8-K 001-38442 10.1 11/20/2024
19.1 Ibex Limited Insider Trading Policy
X
21.1 List of Subsidiaries
X
23.1 Consent of Deloitte & Touche LLP, independent registered public accounting firm
X
31.1 Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act
X
31.2 Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act
X
32.1 Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350
X
97 Compensation Recoupment (Clawback) Policy
10-K 001-38442 97 09/12/2024
101.INS Inline XBRL Instance Document X
101.SCH Inline XBRL Taxonomy Extension Schema Document X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X
105
Table of Contents
Incorporated by Reference
Exhibit
Number Description of Document Form File Number Exhibit Filing
Date Filed or
Furnished
Herewith
104 Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101) X
_______________________
^ Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.
# Certain schedules and exhibits to or portions of this Exhibit have been omitted in accordance with Item 601(a)(5)-(6) and Item 601(b)(10)(iv) of Regulation S-K. The Company hereby agrees to furnish supplementally a copy of all omitted schedules to the SEC upon request.
* Corrected version of a previously filed exhibit (previously filed October 14, 2021 as Exhibit 10.40)
ITEM 16. FORM 10-K SUMMARY
None.
106
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
IBEX LIMITED
By: /s/ Robert Dechant
Name:
Robert Dechant
Title: Chief Executive Officer
(Principal Executive Officer)
Date: September 10, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature Title Date
/s/ Robert Dechant Chief Executive Officer and Director
Robert Dechant (Principal Executive Officer) September 10, 2026
/s/ Taylor Greenwald Chief Financial Officer
Taylor Greenwald (Principal Financial and Accounting Officer) September 10, 2026
/s/ John Jones
John Jones Director and Chairman of the Board September 10, 2026
/s/ Daniella Ballou-Aares
Daniella Ballou-Aares Director September 10, 2026
/s/ Karen Batungbacal
Karen Batungbacal Director September 10, 2026
/s/ Fiona Beck
Fiona Beck Director September 10, 2026
/s/ Shuja Keen
Shuja Keen Director September 10, 2026
/s/ Patrick McGinnis
Patrick McGinnis Director September 10, 2026
/s/ Mingzhe (JJ) Zhuang
Mingzhe (JJ) Zhuang Lead Independent Director September 10, 2026
107